CLOSE
“IBI believes that regenerative medicine represents the future for health, actives from more than 10 years in human regeneration technologies, we are strongly convinced this is the right moment to invest and expand our portfolio in the veterinary applications. After several months of investigation, IBI recognizes in TheraVet SA the right and strongest partner to achieve this important milestone”.
With these sentences Gianni Pertici Ph.D., Chief Executive Officer of Industrie Biomediche Insubri SA, announces the beginning of the partnership with TheraVet SA in order to increase their portfolio with BIOCERA-VET® SmartGraft, a new bone graft developed for the veterinary surgery that applies the same innovative characteristics of SmartBone.
Read the official press releases, by clicking here.
IBI SA
Industrie Biomediche Insubri SA
via Cantonale 67, CH-6805 Mezzovico-Vira, Switzerland
t. +41 91 93.06.640
f. +41 91 220.70.00